Agency Will Fund Research On Development Roadblocks; Orphan Drug Grants Are Model
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is going to fund research projects aimed at eliminating barriers to product development as part of its "critical path" initiative
You may also be interested in...
FDA Plans “Critical Path” Workshop On Prevention Therapies
Two-day meeting will focus on both broad and disease-specific topics related to prevention development hurdles.
FDA Plans “Critical Path” Workshop On Prevention Therapies
Two-day meeting will focus on both broad and disease-specific topics related to prevention development hurdles.
FDA's "Critical Path" Leads To Pharmaceutical Science Advisory Committee Meeting
The committee will discuss research opportunities under FDA's "Critical Path" initiative. Other topics for the Oct. 19-20 meeting include manufacturing, the risk-based GMP initiative, parametrics and generic drug equivalence.